Source: International Congress 2016 – Advancements in bronchoscopy
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Shiyue Li (Guangzhou, China), Shiyue Li, Guangfa Wang, Changhui Wang, Faguang Jin, Xinglin Gao, Huaping Yang, Baohui Han, Rui Zhou, Chengshui Chen, Liang’an Chen, Chunxue Bai, Shen Huahao, Nanshan Zhong. LATE-BREAKING ABSTRACT: The REACH study, a randomized controlled trial assessing the safety and effectiveness of the spiration valve system intra-bronchial therapy for severe emphysema. Eur Respir J 2016; 48: Suppl. 60, 3013

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: A multicenter, prospective, randomized, controlled trial of endobronchial valve therapy vs standard of care in homogeneous emphysema (IMPACT) Source: International Congress 2016 – Endoscopic lung volume reduction I Year: 2016 The REACH study, a randomized controlled trial assessing the safety and effectiveness of the Spiration Valve System endobronchial therapy for severe emphysema: 12 month follow-up results. Source: International Congress 2017 – Interventional pulmonology highlights 2017 Year: 2017 LATE-BREAKING ABSTRACT: Treating the most diseased segments in patients with severe emphysema: 6 month results from the STEP-UP randomized controlled trial (RCT) Source: International Congress 2015 – Advances in therapeutic bronchoscopy Year: 2015 Home nasal high-flow following severe COPD exacerbation: a mixed-methods feasibility randomised controlled trial Source: Virtual Congress 2021 – New trends in non-invasive respiratory support Year: 2021 LATE-BREAKING ABSTRACT: The RENEW trial: Predictors of effectiveness of endobronchial coil therapy in patients with advanced emphysema Source: International Congress 2016 – Airway stenting and ablation Year: 2016 European multicenter, blinded and randomized study design to evaluate the effectiveness of bronchoscopic airway valve placement for the treatment of advanced emphysema Source: Annual Congress 2007 - Interventional bronchoscopy Year: 2007 STEP-UP randomized controlled trial of vapor ablation in patients with severe emphysema: 12 month results Source: International Congress 2016 – Endoscopic lung volume reduction I Year: 2016 A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol Source: ERJ Open Res, 5 (4) 00186-2019; 10.1183/23120541.00186-2019 Year: 2019 Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: Randomised controlled trial Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 LATE-BREAKING ABSTRACT: A cluster randomised controlled trial evaluating the effectiveness of a structured pulmonary rehabilitation education programme in a primary care setting for people with chronic obstructive pulmonary disease (COPD): The PRINCE Study. Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 Update on the European multicenter, blinded and randomized study of bronchoscopic placement of valves for the treatment of severe emphysema Source: Annual Congress 2008 - New trends in interventional pulmonology Year: 2008 Efficacy and safety of isoproterenol continuous inhalation treatment for acute severe exacerbation of asthma in children; a randomized, double-blind controlled study Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015 Efficacy and safety of abediterol (LAS100977) in patients with COPD: Phase II, randomised, crossover study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013 Long-term efficacy of a home-based airway clearance programme to improve cough severity in patients with bronchiectasis:a randomised controlled trial> Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019 An interactive web-based pulmonary rehabilitation programme: A randomised controlled feasibility trial Source: International Congress 2016 – Best abstracts in physical activity and telemedicine Year: 2016 Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial Source: Virtual Congress 2021 – ALERT: COPD Year: 2021 Effectiveness of a pharmacist-led inhalation technique intervention on asthma and COPD patients: The INspira cluster-randomized controlled trial Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 LATE-BREAKING ABSTRACT: Does adding telemonitoring to optimised management of chronic obstructive pulmonary disease (COPD) reduce hospital admissions? Randomised controlled trial Source: Annual Congress 2012 - New insights in pneumology - ERS inter-Assemblies late-breaking abstracts Year: 2012 Safety and benefit of adjunctive systemic corticosteroid therapy in the management of severe, smear positive pulmonary tuberculosis (SSP-PTB); an interim analysis of a randomized controlled trial Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012